Shadan Brings Multi-Perspective View Of Medtech To AdvaMed Accel Chair Post
Executive Summary
Device tax, reimbursement predictability and empowering women in the medtech industry are some of Martha Shadan's top priorities for her two-year term as board chair of AdvaMed Accel, the small-company-advocacy arm of the trade group.
You may also be interested in...
Q&A: AdvaMed Accel's Shadan, Wittorf Outline Lobbying Priorities, More
In a podcast exclusive with Medtech Insight, the new chair and executive director of small-company-focused AdvaMed Accel discussed their priorities for supporting small medtech companies. Among the topics discussed were the medical device tax, reimbursement uncertainty and empowering women in the industry.
DC Reflections: Mark Leahey On MDMA's 2018 Priorities And The Medtech Landscape
In an interview with Medtech Insight, MDMA CEO Mark Leahey talked about the industry group's ongoing efforts to fully repeal the medical device tax, reimbursement challenges, cybersecurity and more. Check out the summary, the podcast and the transcript.
Medicare Will Look To Informal Pathways For Faster Medtech Reimbursement
The US Centers for Medicare and Medicaid Services has withdrawn efforts on a proposed rule to offer faster Medicare reimbursement to novel devices, but the agency still plans to work on different approaches to provide "timely patient access" to device innovations, a spokeswoman said. AdvaMed says it is disappointed by CMS's decision to withdraw the rule after a 10-month review by the Office of Management and Budget.